Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 15 May 2024 06:43:21 +0200Wed, 07 Feb 2024 08:28:00 +0100Human medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xigduoHuman medicines European public assessment report (EPAR): Xigduo, dapagliflozin,metformin, Date of authorisation: 16/01/2014, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/xigduoWed, 07 Feb 2024 08:28:00 +0100Human medicineXigduo : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-2672-summary_en.pdfXigduo : EPAR - Medicine overviewhttps://www.ema.europa.eu/system/files/documents/overview/h-2672-summary_en.pdfThu, 29 Aug 2019 01:00:00 +0200Human medicine